Lonza | LONN - Ebitda





Ebitda تغيير تاريخ
Akzo Nobel EUR 388M 10M 2026-09
Alcon AG USD 795M 478M 2026-03
Almirall EUR 114.07M 60.37M 2025-12
AstraZeneca USD 7.46B 2.3B 2026-09
BASF EUR 1.64B 806M 2026-09
Bayer EUR 1.62B 529M 2026-09
Beiersdorf EUR 926M 58M 2026-06
Covestro EUR 117M 125M 2025-12
Demant DKK 2.8B 47M 2026-06
Fresenius EUR 988M 37M 2026-06
Fresenius Medical Care EUR 817M 26.66M 2026-09
Geberit CHF 177.6M 58.4M 2025-12
Genmab DKK 401M 186M 2026-06
Givaudan CHF 778M 195M 2025-12
GlaxoSmithKline GBP 3.51B 734M 2026-06
GN Store Nord DKK 352M 139M 2026-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Johnson Matthey GBP 325M 52M 2024-06
Merck EUR 1.6B 69M 2026-06
Novartis USD 8.62B 2.14B 2026-09
Philips EUR 772M 138M 2026-09
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 5.79B 2.1B 2026-09
Sika AG CHF 994.3M 76.1M 2025-12
Smith & Nephew USD 796M 139M 2025-12
Solvay EUR 187M 32M 2026-06
UCB EUR 1.6B 570M 2025-12